Wire Stories
AVITA Therapeutics to Participate at the Canaccord Genuity 40th Annual Growth Conference
VALENCIA, Calif. & MELBOURNE, Australia–(BUSINESS WIRE)–AVITA Therapeutics, Inc. (NASDAQ: RCEL) (ASX:AVH), a regenerative medicine company that is developing and commercializing a technology...